3rd Annual Symposium: Pulmonary Embolism – A State of the Art Update

Cambridge, MA
June 23 – 24, 2017


Target Audience

This live educational program is intended for clinicians who regularly care for patients with pulmonary embolism (PE), as well as those who are interested in studying the pathophysiology, epidemiology, diagnosis, medical and interventional management, novel treatment paradigms, and outcomes of PE – including acute and chronic.

Educational Goal

The goal of this symposium is to provide information on the pathophysiology, epidemiology, diagnosis, prevention, and treatment of PE by educating our medical colleagues through a series of lectures and interactive discussions with thought leaders in the field.

Learning Objectives

  • Develop a diagnostic and treatment algorithm for PE that incorporates risk stratification and meets the specific needs of patients presenting with symptoms/signs suggestive of PE
  • Identify low-, moderate-, and high-risk PE
  • Select among various treatment options for moderate- and high-risk PE patients including anticoagulation (type of agent and delivery model, IVC filter placement, thrombolysis (intravenous and catheter-directed), extracorporeal membrane oxygenation (ECMO), suction thrombectomy and open surgical thrombectomy
  • Apply standards of care for post-PE long-term management and surveillance
  • Describe the unique patient populations with PE and their specific treatment challenges

Planner Disclosures

No member of CMEsolutions or Gaffney Events has any relevant financial relationships to disclose.

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CMEsolutions and Gaffney Events.The CMEsolutions is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The CMEsolutions designates this live activity for a maximum of 12.50 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Fees

There is a registration fee for this activity as explained at www.pertconsortium.org

Participation Requirements

  1. Complete sign in sheet
  2. Attend credit designated sessions
  3. Log in to https://online-med-edu.com/PE/portal/2017 complete evaluation, credit request form, and download or print credit statement

Faculty and Disclosures

CMEsolutions has resolved all conflicts of interest prior to this educational activity through the following procedures:

  • All potential conflicts have been discussed with the speakers and all have agreed to the Conflict of Interest policy
  • All presentations have been peer reviewed for conflict or bias
  • All participants have signed a disclosure statement indicating they will present information fairly and without bias
  • The Symposium will be monitored to insure no conflicts of interest arise

William R. Auger, MD
Professor of Clinical Medicine, UC San Diego School of Medicine
San Diego, CA
Geoffrey Barnes has disclosed the following relevant financial relationships: Bayer – Research Grant Support and reimbursement for travel expenses and speaker honorarium.

Geoffrey D. Barnes, MD, MSc
Clinical Lecturer, University of Michigan Health System
Northville, MI
Geoffrey Barnes has disclosed the following relevant financial relationships: BMS/Pfizer – Research Grant Funding and Consulting Fee; Portola – Consulting fee; Blue Cross Blue Shield of Michigan – salary and research grant funding; NIH/NHLBI – salary/research grant funding.

John R. Bartholomew, MD, MSVM, FACC
Professor of Medicine, Lerner College of Medicine, Cleveland Clinic
Cleveland, OH
John Bartholomew has no relevant financial relationships to disclose.

James F. Benenati, MD, FSCIR, FAHA
Medical Director, Peripheral Vascular Laboratory, Clinical Associate Professor of Radiology, Cleveland Clinic
Cleveland, OH
James Benenati has disclosed the following relevant financial relationships: Penmubra – consulting fees/royalities; Gore – consulting fees; Merit – consulting fees; Cook – consulting fees; Bard – consulting fees.

Keri O. Brenner, MD, MPA
Palliative Care Physician and Psychiatrist, Massachusetts General Hospital
Boston, MA
Keri Brenner has no relevant financial relationships to disclose.

Richard N. Channick, MD
Director, Pulmonary Hypertension and Thromboendarterectomy Program, Mass General Hospital for Children
Boston, MA
Richard Channick has no relevant financial relationships to disclose.

George A. Davis, PharmD, BCPS
Anticoagulation Program Coordinator, Associate Adjunct Professor, University of Kentucky
Lexington, KY
George Davis has disclosed the following relevant relationships: Stock - Nutrigenomix

David Dudzinski, MD
Cardiologist, Instructor of Medicine, Massachusetts General Hospital
Boston, MA
David Dudzinski has no relevant financial relationships to disclose.

Maher D. Elder, MD
Medical Director, Cardiac Care Unit Chief of Cardiology, Ambulatory Services Program Director of Cardiac CT Angiogram, Clinical Associate Professor of Medicine at Wayne State University School of Medicine, Assistant Program Director of Interventional Fellowship at Wayne State University School of Medicine and Director of Endovascular Medicine at DMC University Hospital, Detroit Medical Center
Detroit, MI
Maher Elder has disclosed the following relevant relationships: Abiomed – consulting; EKOS – consulting.

John Fanikos, MBA, RPh
Residency Program Director, Executive Director of BWH Pharmacy Business and Financial Services, Brigham & Women’s Hospital
Boston, MA
John Fanikos has disclosed the following relevant relationships: Portola Pharmaceuticals – honorarium; Boehringer-Ingelheim – honorarium.

Brian B. Ghoshhajra, MD, MBA
Service Chief, Cardiovascular Imaging, Assistant Professor of Radiology, Massachusetts General Hospital Harvard Medical School
Boston, MA
Brian Ghoshhajra has no relevant financial relationships to disclose

Jay S. Giri, MD, MPH
Director - Peripheral Intervention, Associate Director - CV Outcomes, Quality & Evaluation Research Center, University of Pennsylvania
Philadelphia, PA
Jay Giri has no relevant financial relationships to disclose.

Samuel Z. Goldhaber, MD
Director, Thrombosis Research Group, Professor, Harvard Medical School, Brigham and Women's Hospital
Boston, MA
Samuel Goldhaber has disclosed the following relevant relationships: Bi02 – Grant support; Boehringer-Ingelheim – grant support/consulting fees; BMS – grant support/consulting fees; BTG EKOS – grant support; Daichi – grant support/consulting fees.

Emily Gundert, MD
Assistant Professor, Emergency Medicine, UT Southwestern
Dallas, TX
Emily Gundert has no relevant financial relationships to disclose.

John A. Heit, MD
Professor Emeritus of Medicine, Department of Cardiovascular Diseases, Laboratory Medicine/Pathology, Mayo Clinic
Rochester, MN
John Heit has no relevant financial relationships to disclose.

Gustavo A. Heresi, MD
Medical Director of the Pulmonary Thromboendarterectomy Program, Department of Pulmonary and Critical Care Medicine, Respiratory Institute at Cleveland Clinic
Assistant Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University Department of Pulmonary and Critical Care Medicine in the Respiratory Institute
Cleveland, OH
Gustavo Heresi has no relevant financial relationships to disclose.

Michael R. Jaff, DO
President - Newton-Wellesley Hospital, Medical Director, Mass General Vascular Center
Founder and Medical Director, VasCore, the Vascular Ultrasound Core Labratory
Medical Director, Center for Specialized Services, Newton-Wellesley Hospital, Massachusetts General Hospital
Newton, MA
Michael Jaff has disclosed the following relevant relationships: Boston Scientific – Non-compensated advisor; Cordis - Non-compensated advisor; VIVA Physicians – Board compensation; Embolitech – Equity; Venarum – Equity.

Christopher Kabrhel, MD, MPH
Emergency Medicine Physician, MassGeneral Hospital for Children
Boston, MA
Cristopher Kabrhel has disclosed the following relevant relationships: Janssen Pharmaceuticals – grant to my institution/consulting agreement with my institution; Siemens Healthcare- grant to my institution/consulting agreement with my institution; Diagnostica Stago – grant to my institution/consulting agreement with my institution; Boehringer-Ingelheim – grant to my institutuion.

Mihir M. Kamdar, MD
Associate Director, Division of Palliative Care, Massachusetts General Hospital, Division of Palliative Care & Geriatrics, Division of Anesthesia Pain Medicine
Boston, MA
Mihir Kamdar has no relevant financial relationships to disclose.

W. Brent Keeling, MD
Director, MGH Cancer Pain Clinic, Emory University School of Medicine
Atlanta, GA
W. Brent Keeling has no relevant financial relationships to disclose.

Alok A. Khorona, MD, FACP
Professor of Medicine, Sondra and Stephen Hardis Chair in Oncology Research, Vice-Chair for Clinical Service, Taussig Cancer Institute, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Cleveland, OH
Alok Khorana has disclosed the following relevant financial relationships: Janssen – honoraria/research funding; Sanofi – honoraria; Bayer – honoraria; Pfizer – honoraria.

Andrew J.P. Klein, MD, FACC, FSCAI
Interventional Cardiology, Piedmont Heart Institute
Atlanta, GA
Andrew Kline has no relevant financial relationships to disclose.

Jeffrey A. Kline, MD
Professor and Vice Chair of Research, Emergency Medicine, Indiana University, Department of Emergency Medicine
Indianapolis, IN
Jeffrey Kline has disclosed the following relevant financial relationship: Indiana Lysis Technologies, LLC – Founder; Janssen Pharmaceuticals – consultant; Mallinckrodt – grant/research support; NIH – grant/research support; Roche Diagnostics – grant/research support.

Christopher J. Kwolek, MD
Training Program Director in Vascular and Endovascular Surgery – MGH; Chief of Vascular and Endovascular Surgery – NWH, Massachusetts General Hospital
Boston, MA
Christopher J. Kwolek has no relevant financial relationships to disclose.

Matthew D. Langston, MD
Professor of Cellular and Integrative Physiology, Albert Einstein College of Medicine, Jacobi Medical Center
Bronx, NY
Matthew Langston has no relevant financial relationships to disclose.

Rutger J. Lely, MD
Interventional  Radiologist, VU University Medical Center
Amsterdam, The Netherlands
Rutger Lely has disclosed the following relevant financial relationship: BTG – Consulting fee; Philips – consulting fee.

Robert Maholic, DO
Interventional Cardiology, Medicor Associates
Erie, PA
Robert Maholic has disclosed the following relevant financial relationships: EKOS – consulting fee/honoraria; Abbott Vascular - honoraria.

Geno J. Merli, MD, MACP, FHM, FSVM
Professor of Medicine, Co-Director, Jefferson Vascular Center, Jefferson Medical College
Philadelphia, PA
Geno Merli has disclosed the following relevant financial relationships: BMS – grant/research support/scientific consultant; Johnson & Johnson - grant/research support/scientific consultant; Sanofi-Aventis - grant/research support/scientific consultant; Portola – grant/research support; Janssen Scientific Affairs – rant/research support.

Jana Montgomery, MD
Cardiovascular Medicine, Lahey Hospital and Medical Center
Burlington, MA
Jana Montgomery has no relevant financial relationships to disclose.

Jose Pablo Morales, MD
Medical Officer, U.S. Food and Drug Administration
Silver Springs, MD
Jose Pablo Morales has no relevant financial relationships to disclose.

Jonathan Moriarty, MD, RPVI
Director, Interventional Innovation, Co-Director Vascular Ultrasound Service, David Geffen School of Medicine at UCLA
Los Angeles, CA
Jonathan Moriarty disclosed the following relevant financial relationships: Argon Medical – consulting fee/honoraria; Angiodynamics - honoraria.

Ruth Morrison, RN, BSN
Clinical Research Coordinator, Brigham and Women's Hospital
Boston, MA
Ruth Morrison disclosed the following relevant financial relationships: BTG – consulting fee; Philips – consulting fee.

Jeffrey W. Olin, DO, FACC, FAHA
Professor of Medicine, Cardiology, Director, Vascular Medicine, Zena and Michael A. Wiener Cardiovascular Institute & Marie-Jose and Henry R. Kravis Center for Cardiovascular Health
Ichan School of Medicine at Mount Sinai, The Mount Sinai Hospital
New York, NY
Jeffrey Olin has no relevant financial relationships to disclose.

Thomas Lee Ortel, MD, PhD
Professor of Medicine, Chief, Division of Hematology, Department of Medicine, Professor of Pathology, Duke University School of Medicine
Durham, NC
Thomas Lee Ortel has no relevant financial relationships to disclose.

Gregory Piazza, MD
Instructor, Brigham and Women's Hospital, Harvard Medical School
Boston, MA
Gregory Piazza disclosed the following relevant financial relationships: BMS – grant; Janssen – grant; EKOS BTG – grant; Daiichi-Sankyo - grant.

Belinda N. Rivera-Lebron, MD
Pulmonologist, University of Pittsburgh Medical Center
Pittsburgh, PA
Belinda Rivera-Lebron disclosed the following relevant financial relationships: Gilead – advisory board participant; Actelion – institutional grant/no direct monetary receipts.

Josanna M. Rodriguez-Lopez, MD
Director of the Hereditary Hemorrhagic Telangiectasia Center (HHT), Massachusetts General Hospital
Boston, MA
Josanna Rodriguez-Lopez has no relevant financial relationships to disclose.

Kenneth Rosenfield, MD, MHCDS
Section Head, Vascular Medicine and Intervention, Chairman, STEMI & Acute MI Quality Improvement Committee, Massachusetts General Hospital
Boston, MA
Kenneth Rosenfield has no relevant financial relationships to disclose.

Rachel P. Rosovsky, MD, MPH
Hematology / Oncology Physician, Massachusetts General Hospital
Boston, MA
Rachel Rosovsky has no relevant financial relationships to disclose.

Charles B. Ross, MD, FACS
Chief of Vascular and Endovascular Services Department of Surgery, Piedmont Heart Institute
Atlanta, GA
Charles Ross has no relevant financial relationships to disclose.

Nathalie Roy, MD
Vascular Surgeon, Massachusetts General Hospital
Boston, MA
Nathalie Roy has no relevant financial relationships to disclose.

Robert M. Schainfeld, MD
Associate Director, Vascular Medicine, Massachusetts General Hospital
Boston, MA
Robert Schaingeld has no relevant financial relationships to disclose.

Daniel R. Schimmel, Jr., MD, MS
Assistant Professor of Medicine, Bluhm Cardiovascular Institute, Northwestern Medicine
Chicago, IL
Daniel Schimmel has no relevant financial relationships to disclose.

Akhilesh K. Sista, MD, FSIR
Associate Professor, Vascular and Interventional Radiology, Section Chief, Vascular Interventional Radiology, NYU Langone School of Medicine
New York, NY
Akhilesh Sista disclosed the following relevant financial relationships: Enumbra, Inc. – unrestricted research grant administered through NYU School of Medicine.

David A. Slosky, MD
Assistant Professor of Medicine, Vanderbilt Heart
Nashville, TN
David Slosky has no relevant financial relationships to disclose.

Roy E. Smith, MD
Professor of Medicine, University of Pittsburgh Medical Center
Pittsburgh, PA
Roy Smith has no relevant financial relationships to disclose.

Victor Tapson, MD
Director, Venous Thromboembolism and Pulmonary Vascular Disease Research Program, Director, Clinical Research, Women’s Guild Lung Institute, Associate Director, Pulmonary and Critical Care Medicine, Cedars-Sinai Medical Center
Los Angeles, CA
Victor Tapson has no relevant financial relationships to disclose.

Thomas M. Todoran, MD, MSc
Assistant Professor, Medical University of South Carolina
Charleston, SC
Thomas Todoran has disclosed the following relevant financial relationships: GE Healthcare – consulting fee; Medronic – consulting fee.

Mauricio A. Villavicencio, MD, MBA
Surgical Director of Lung Transplantation and Extracorporeal Membrane Oxygenator Programs, Massachusetts General Hospital Radiological Associates
Boston, MA
Mauricio A. Villavicencio has no relevant financial relationships to disclose.

T. Gregory Walker, MD
Associate Fellowship Director, Vascular Imaging and Intervention, Massachusetts General Hospital Radiological Associates
Boston, MA
T. Gregory Walker has no relevant financial relationships to disclose.

Ido Weinberg, MD
Associate Director, Vascular Medicine and Intervention Fellowship, Massachusetts General Hospital
Boston, MA
Ido Weinberg has no relevant financial relationships to disclose.

Philip Wells, MD, FRCPC, MSc
Professor, Chair and Chief Department of Medicine, Senior Scientist Ottawa Hospital Research Institute, University of Ottawa l Université d’Ottawa, The Ottawa Hospital
Ottawa, Canada
Philip Wells has disclosed the following relevant financial relationships: Bayer Healthcare – honoraria for speaker fees; Itreas – honoraria for writing committee.

Alison S. Witkin, MD
Instructor of Medicine, Massaschusetts General Hospital
Boston, MA
Alison Witkin has no relevant financial relationships to disclose.

Charlie Yongpravat, PhD
Biomedical Engineer, U.S. Food and Drug Administration
Silver Springs, MD
Charlie Yongpravat has no relevant financial relationships to disclose.

Off-label Use

3rd Annual Symposium: Pulmonary Embolism – A State of the Art Updatemay contain discussion of unlabeled and/or investigational uses of agents not approved by the FDA.  Please consult the prescribing information for each product.

Commercial Support

Commercial Support for 3rd Annual Symposium: Pulmonary Embolism – A State of the Art Update has been provided by:

  • Bayer Healthcare Pharmaceuticals
  • Biocompatibles, Inc (a BTG International Group Company – EKOS)
  • Chiesi USA, Inc.
  • Cook Medical LLC
  • Medtronic (Aortic and Peripheral Vascular)
  • Philips Volcano

Privacy Policy

CMEsolutions Privacy and Confidentiality Policy: www.online-med-edu.com/privacypolicy.pdf
CMEsolutions can be contacted at info@cmesolutions.org .


 complete evaluation/credit request